This study is currently not recruiting participants.

Characterization of digoxin therapeutic drug monitoring and incidence of toxicity in pediatric patients with congenital heart disease

Investigating Serum Monitoring in Children with Single Ventricle

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to characterize the extent of digoxin serum concentration monitoring currently being performed in children born with only one heart ventricle in order to quantify the incidence of supratherapeutic concentrations discovered.

Detailed description of study

The purpose of this study is to characterize the extent of digoxin serum concentration monitoring currently being performed in children born with only one heart ventricle in order to quantify the incidence of supratherapeutic concentrations discovered.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: congenital heart disease
  • Age: 100 years or below
  • Gender: All

This study investigates how often digoxin serum concentration is monitored in children who are born with only one heart ventricle. Digoxin is a medication used to help the heart work better, and it's important to check its levels in the blood to ensure safety.

The study aims to find out how many children have high levels of digoxin in their blood. This involves checking the blood concentration of digoxin to see if it is too high, which can be harmful.

  • Who can participate: Children born with only one heart ventricle who are receiving digoxin treatment may be eligible to participate.
  • Study details: Participants will have their blood tested to measure digoxin levels. This will assist in determining if the levels are too high, which could be dangerous.
Updated on 19 Feb 2024. Study ID: 1709259753

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team